We assess brain structure, function, and physiology in patients with neurological injury or disease to guide patient management and clinical decision making.
Another way of saying it is:
We focus on neurological disorders
The number of people impacted by neurological disease is large and continues to grow. The result is a tremendous economic cost to society and on quality of life for patients and caregivers. Because of this, we have focused our platform on this specific topic area.
We use multimodal imaging
Multimodal imaging simply means that we combine multiple types of imaging to assess injury and predict outcome. Conventional MRI or CT generally looks at the structures of the brain. By including other imaging modalities we are able to provide greater insight into the health of your brain.
This is personalized medicine
In general, we all have the same regions and structures within our brain. However, there are subtle variations between individuals and because of this, we tailor our evaluation of your injury to how your brain is organized.
We provide a concrete metric for prognosis
Many diagnoses are based on clinical opinion and tests that rule out alternative causes for the symptoms as opposed to a positive diagnosis. Clinical opinion is also used to estimate recovery time or prognosis. By providing a quantitative indicator of disease and severity, we provide another source of information to guide a clinician's decision making process.
VOXEL Solution
At Voxel.AI we have developed our technology to provide patients and their entire care team with insight about their neurological health by using information that is not currently available with other techniques.
We use multimodal imaging to localize dysfunction not identifiable on traditional neuroimaging. Our analysis can be used to estimate patient prognosis, develop a customized rehabilitation strategy and monitor recovery.
Still Reading?
About Us
Through the experience of our clinicians and scientists, we identified that many aspects of diagnosis, management, prediction of recovery and progression rely solely on clinical opinion rather than quantitative indicators.
Collaborators
Improving the diagnosis, management and prognostication of neurological disorders is a challenge that will require support from a diverse group of partners. At Voxel.AI we are always looking to make new connections.
Investors
As we grow our technology and expand into new indications, we are excited to share our progress and goals for the future with our investor community. We expect to be actively fundraising again in September 2021.